Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
12/1998
12/09/1998EP0882130A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
12/09/1998EP0881905A1 Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
12/09/1998EP0881886A1 Animal feed
12/09/1998EP0881884A1 Bacterial delivery system
12/09/1998EP0332667B2 Vector for integration site independent gene expression in mammalian host cells
12/09/1998CN1201374A Lactose-containing food composition for infants
12/09/1998CN1200936A Traditional Chinese medicine extract tablet and preparation method therefor
12/09/1998CN1200934A Lactobacillus ointment for treatment of vaginal diseases and preparation method therefor
12/09/1998CN1200927A Method for extracting earthworm element from Jpan Dula earthworm
12/09/1998CN1041055C Method for making sterilizing incense for poultry
12/08/1998US5847084 Process for obtaining platelet factor-4
12/08/1998US5847082 Terminal complement inhibitor fusion proteins
12/08/1998US5846954 Cyclodextrin compounds and methods of making and use thereof
12/08/1998US5846945 Cytopathic viruses for therapy and prophylaxis of neoplasia
12/08/1998US5846928 Method for treating cancer patients
12/08/1998US5846827 Methods for ex vivo therapy using peptide-loaded antigen presenting cells for the activation of CTL
12/08/1998US5846806 Identification of a human cytomegalovirus gene region involved in down-regulation of MHC class I heavy chain expression
12/08/1998US5846796 Blood-borne mesenchymal cells
12/08/1998US5846755 Method for determining the therapeutic activity of metalloproteinase inhibitor compounds
12/08/1998US5846712 Tumor suppressor gene, HIC-1
12/08/1998US5846569 Colostrum supplement
12/08/1998US5846548 Combined administration of mitogenic immumo stimulator and a thymomimetic
12/08/1998US5846546 Preparation and use of viral vectors for mixed envelope protein immunogenic composition against human immunodeficiency viruses
12/08/1998US5846540 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments
12/08/1998US5846529 Infusion of neutrophil precursors for treatment of neutropenia
12/08/1998US5846528 Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence
12/04/1998CA2233587A1 Novel compounds
12/03/1998WO1998054346A1 Alternatively targeted adenovirus
12/03/1998WO1998054322A1 Osf2/cbfa1 compositions and methods of use
12/03/1998WO1998054318A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33
12/03/1998WO1998054311A1 Zinc finger protein derivatives and methods therefor
12/03/1998WO1998054301A2 Transplants for myocardial scars and method and cellular preparations therefor
12/03/1998WO1998054226A1 Processes for production of immunoglobulin a in milk
12/03/1998WO1998054213A2 Neurotrophic factor receptors
12/03/1998WO1998053853A1 Combined product associating a nucleic acid with a substance breaking up the extracellular matrix for gene therapy
12/03/1998WO1998053845A1 Synthetic, statistic thymus peptide combination and its use as a preparation with immunological and/or endocrinological effect
12/03/1998WO1998053836A1 Improved gelled oxygen products
12/03/1998WO1998045712A3 20 human secreted proteins
12/03/1998CA2291861A1 Zinc finger protein derivatives and methods therefor
12/03/1998CA2291698A1 Osf2/cbfa1 compositions and methods of use
12/03/1998CA2291590A1 Combined product associating a nucleic acid with a substance breaking up the extracellular matrix for gene therapy
12/03/1998CA2291487A1 Processes for production of immunoglobulin a in milk
12/03/1998CA2291323A1 Alternatively targeted adenovirus
12/03/1998CA2288235A1 Tumour suppressor gene dbccr1 at 9q32-33
12/02/1998EP0880695A1 Prolonged preservation of blood platelets
12/02/1998EP0880354A1 Urogenital and intestinal compositions
12/02/1998EP0772484A4 Fibrous web and process of preparing same
12/02/1998CN1200675A 流感疫苗 Influenza vaccination
12/02/1998CN1200295A Quick action powder medicine for reunion of broken bone
12/02/1998CN1200294A Medicine for treating hernia
12/02/1998CN1200288A Tung oil plaster for reinforcing muscles and strengthening bones
12/02/1998CN1200277A Compound oral liquid medicine for treating psychosis and nerve system disease
12/02/1998CN1200276A Medicine for lowering blood-sugar and nourishing the heart and method for preparing same
12/02/1998CN1200272A Immunologic facilitation agent for inhibiting growth of tumor
12/02/1998CN1200271A Process and device for processing ants sectionally
12/01/1998US5844098 Reconstituted platelet membrane vesicles
12/01/1998US5844079 Vertebrate embryonic pattern-inducing proteins, and uses related thereto
12/01/1998US5843920 Anionic saccharides for extraction of anti-angiogenic protein from cartilage
12/01/1998US5843913 Nucleic acid respiratory syncytial virus vaccines
12/01/1998US5843892 Stimulation of nerve growth and/or vitality
12/01/1998US5843882 Antiviral proteins and peptides
12/01/1998US5843778 Use of chimeric vaccinia virus complement control proteins to inhibit complement
12/01/1998US5843743 Gels for encapsulation of biological materials
12/01/1998US5843688 Isolated tyrosinase derived peptides and uses thereof
12/01/1998US5843687 Isolated, tyrosinase derived peptides and uses thereof
12/01/1998US5843679 Method for selectively enhancing the production of factors A or B0 of antibiotic A 40926 complex
12/01/1998US5843474 Method of dialysis treatment, and dialysis apparatus related thereto
12/01/1998US5843458 Recombinant human cytomegalovirus having a US2 deletion
12/01/1998US5843441 Use of endothelial-leukocyte adhesion molecule-1 specific antibodies in the treatment of asthma
12/01/1998US5843438 Peripheralization of hematopoietic stem cells
12/01/1998US5843437 A82846 antibiotics
12/01/1998US5843435 Immunotherapy of cancer with allogeneic lymphocytes
12/01/1998US5843430 Methods of treating disease using sertoli cells and allografts or xenografts
12/01/1998US5843425 Transplantation and graft-versus-host-disease
12/01/1998CA2042494C Photodynamic inactivation of viruses in cell-containing compositions
11/1998
11/27/1998CA2206180A1 Treatment of chronic post-traumatic pain syndromes
11/26/1998WO1998053075A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
11/26/1998WO1998052629A2 Cell processing systems
11/26/1998WO1998052619A2 Peptide-coated implants and methods for producing same
11/26/1998WO1998052597A1 Apoptosis-inducing gelsolin sequences
11/26/1998WO1998052586A1 Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease
11/26/1998WO1998052585A1 Immunomodulating, bile-derivable compositions for the treatment of viral disorders
11/26/1998WO1998052584A1 A method to increase the survival of transplanted cells
11/26/1998WO1998052583A1 Natural composition for treating bone or joint inflammation
11/26/1998WO1998052582A2 Non-myeloablative tolerogenic treatment
11/26/1998CA2783134A1 Mycobacterium tuberculosis antigens for immunotherapy and diagnosis of tuberculosis
11/26/1998CA2290774A1 Mycobacterium tuberculosis antigens for immunotherapy and diagnosis of tuberculosis
11/26/1998CA2290657A1 A method to increase the survival of transplanted cells
11/26/1998CA2290367A1 Non-myeloablative tolerogenic treatment
11/25/1998EP0879608A2 Means and Method for separating blood in its components
11/25/1998EP0879603A1 Calcium channel antagonist possessing an inhibitory action against secretion of parathyroid hormones and a use thereof
11/25/1998EP0879602A1 A method to increase the survival of transplanted cells
11/25/1998EP0879294A1 Transduced human hematopoietic stem cells
11/25/1998EP0879282A1 Immunotherapy using cytotoxic t lymphocytes (ctl)
11/25/1998EP0879281A2 Methods and compositions for transforming dendritic cells and activating t cells
11/25/1998EP0879280A1 A method for selectively purging cd77?+ cells from bone marrow
11/25/1998EP0879279A1 Diabetes therapy
11/25/1998EP0661998B1 Therapeutic agent from mycobacterium vaccae and its use against hiv infection with aids
11/25/1998EP0633789B1 Wound dressing, wound plaster or carrier matrix
11/25/1998CN1200038A Method for the production of tablets by pressing and tablets produced by the method
1 ... 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 ... 1259